Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase IB/II Study of Onvansertib PCM-075 in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation
Study Type: Treatment
Phase: I/II
NCTID: NCT03829410
Principal Investigator:
Anup Kasi
Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-Type, Left-Sided Colorectal Cancer
Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy COMMIT Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination versus Single Agent Atezolizumab in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair dMMR/Microsatellite Instability-High MSI-H Metastatic Colorectal Cancer
Omega 3 Fatty Acids in Colorectal Cancer CRC Prevention in Patients with Lynch Syndrome COLYNE
Study Type: Prevention
Phase: Feasibility/Pilot
NCTID: NCT03831698
Principal Investigator:
Anwaar Saeed
An Open-label Randomized Trial of the Efficacy and Safety of Zanidatamab with Standard-of-Care Therapy Against Standard-of-Care Therapy Alone for Advanced HER2-Positive Biliary Tract Cancer BTC
A Phase II/III Randomized, Open-Label Study of Maintenance GRT-C901/GRT-R902, A Neoantigen Vaccine, in Combination with Immune Checkpoint Blockade for Patients with Metastatic Colorectal Cancer
Study Type: Treatment
Phase: II/III
NCTID: NCT05141721
Principal Investigator:
Anup Kasi
Exosomal as correlative biomarker in Clinical Outcomes in Patients Undergoing Neoadjuvant Chemoradiation therapy for Rectal Cancer
Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer SOLARIS
Study Type: Treatment
Phase: III
NCTID: NCT04094688
Principal Investigator:
Anup Kasi
A Phase II Trial of Perioperative CV301 Vaccination in Combination with Nivolumab and and Systemic Chemotherapy for Resectable Hepatic-Limited Metastatic Colorectal Cancer
Study Type: Treatment
Phase: II
NCTID: NCT03547999
Principal Investigator:
Anup Kasi